top of page
Image by Federico Pompei

AI Rare Platform

Our approach to rare diseases therapy started from the Search & Match model, initially developed in 2001 by Mondobiotech's founders, and was honored with the WEF Technology Pioneer Award.


Today, MondoRare has advanced this groundbreaking model by integrating state-of-the-art AI technology. 


Our AI Rare platform enhances the accuracy and efficiency of identifying potential therapies, ensuring rapid progression to clinical application.

Image by Greg Rakozy

“Leveraging AI technology to take care of the Rare Diseases Community by finding therapies and promoting sustainable health

bottom of page